Chocoladefabriken Lindt & Spruengli AG (0QKN)
London Exchange · UK · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 86,700.00 |
|---|---|
| 52-week range | 77,500.00 – 132,000.00 |
| Return, 1 month / 3 months | −2.5% / −7.7% |
| Return, 1 year / 3 years | −32.6% / −6.6% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 22.9% |
| Worst drawdown (1 year) | -39.6% |
| Average daily value traded | 1.84M CHF |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chocoladefabriken Lindt & Spruengli AG is a Swiss chocolate maker based in Kilchberg. It produces chocolate bars, pralines and truffles, including its Lindor truffle balls and seasonal Easter chocolate figures, and it also operates its own chain of chocolate shops alongside sales through retailers and duty-free outlets in many countries. The company makes and markets its confectionery under several chocolate brands and serves consumers through grocery stores, department stores and its own retail locations.
On this site Chocoladefabriken Lindt & Spruengli AG appears as a stock on the London Exchange (UK), code 0QKN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chocoladefabriken Lindt & Spruengli AG (0QKN) trades on the London Exchange in UK. It last closed at CHF 86,700.00 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,742 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.6% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.5% | ||
| From 52-week high | -33.7% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -16.2% | ||
| 12-month return, skipping the last month | -30.9% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.6% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.84M CHF | ||
| Zero-volume days | 6.7% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | −2.5% |
| 3 months | −7.7% |
| 6 months | −16.2% |
| 1 year | −32.6% |
| 3 years | −6.6% |
| 5 years | −16.6% |
Signals
| 50-day / 200-day average | 87,555.28 / 100,200.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,259.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | CHF 1,800.0000 |
| 22 Apr 2025 | CHF 1,500.0000 |
| 22 Apr 2024 | CHF 1,400.0000 |
| 24 Apr 2023 | CHF 1,300.0000 |
| 3 May 2022 | CHF 1,200.0000 |
| 6 May 2021 | CHF 731.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.